Genmab A (GMAB) Return on Assets (2023 - 2026)

Genmab A (GMAB) posted Return on Assets of 0.0% for Q1 2026, down 27.71% on a QoQ basis from 0.0% in Q4 2025, and little changed year-over-year from 0.0% in Q1 2025.

Genmab A (GMAB) Return on Assets (2023 - 2026) Analysis & Trends

Genmab A's Return on Assets history runs 4 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed N/A from the prior year.
  • Return on Assets was 0.0% for Q1 2026 at Genmab A, down from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 1073.5% in Q3 2024 and bottomed at 0.0% in Q4 2023.
  • A 4-year average of 134.19% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
  • Annual changes were most pronounced in 2024 — Return on Assets grew 1 bps — and 2025, when it plunged 107349 bps.
  • Genmab A's Return on Assets stood at 0.0% in 2023, then soared by 1410745656 bps to 0.01% in 2024, then tumbled by 77 bps to 0.0% in 2025, then decreased by 28 bps to 0.0% in 2026.
  • Business Quant data shows GMAB's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.01% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -0.69%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00%
4 NuCana 279.75 Bn 279.75 Bn - -0.01%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00%
7 Belite Bio 62.51 Bn 62.51 Bn - -0.80%
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 0.00%
10 Genmab A 1.89 Bn 366.92 Mn 831.00 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.01%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.01%
Sep 30, 2024 1,073.50%
Dec 31, 2023 0.00%